Skip to main content
Log in

Anti-dsDNA: choice of assay in relation to clinical value

  • Serology
  • Published:
Rheumatology International Aims and scope Submit manuscript

Summary

Antibodies to DNA are quite specific for systemic lupus erythematosus (SLE) and occur in the majority of SLE patients. Therefore, their detection is an important diagnostic aid to the clinician. Detection of anti-dsDNA may precede the diagnosis of SLE by more than a year. Fluctuations in the level of anti-dsDNA in an individual patient may give important information on the clinical status of the patient. Four of the most important methods developed for the measurement of anti-dsDNA antibodies will be discussed in this paper: the Farr assay, the PEG assay, the indirect immunofluorescence test on Crithidia luciliae and the ELISA. They will also be compared with one commercially available (Farr) assay, the Amersham anti-dsDNA kit. Each method, detects a part of the spectrum of anti-dsDNA antibodies produced by a patient. The Farr assay is the most specific for SLE; however, milder forms of the disease in which patients have only low avidity anti-dsDNA may easily be missed by this technique. Clinically, high avidity anti-dsDNA is related more frequently to the occurrence of nephritis, whereas low avidity anti-dsDNA antibodies are found more often in patients with central nervous system involvement. Traditionally, SLE is considered an immune-complex disease, in which inflammatory processes are initiated by local deposition of DNA/anti-dsDNA complexes. More recently, a major role was thought to be played by crossreactions of anti-dsDNA with tissue constituents. Our current view, however, is that such a crossreactivity plays only a minor role; we postulate that binding to glomerular constituents is caused by anti-dsDNA antibodies complexed with DNA and histones.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lahita RG (1987) Systemic lupus erythematosus. Wiley, New York, pp 1–1000

    Google Scholar 

  2. Smeenk RJT, Westgeest AAA, Swaak AJG (1985) Antinuclear antibody determination: the present state of dignostic and clinical relevance. Scand J Rheumatol [Suppl] 56:78–92

    Google Scholar 

  3. Tan EM (1989) Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 44:93–152

    Google Scholar 

  4. Koffler D, Agnello V, Thoburn R, Kunkel HG (1971) Systemic lupus erythematosus: prototype of immune complex nephritis in man. J Exp Med 134:169S-179S

    Google Scholar 

  5. Lafer EM, Rauch J, Andrzejewski C Jr, Mudd D, Furie B, Schwartz RS, Stollar DB (1981) Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids. J Exp Med 153:897–909

    Google Scholar 

  6. Shoenfeld Y, Rauch J, Massicotte M, Stollar BD, Schwartz RS (1983) Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas. N Engl J Med 308:414–420

    Google Scholar 

  7. Jacob L, Lety MA, Louvard D, Bach JF (1985) Binding of a monoclonal anti-DNA autoantibody to identical protein(s) present at the surface of several human cell types involved in lupus pathogenesis. J Clin Invest 75:315–317

    Google Scholar 

  8. Faaber P, Rijke GPM, Putte LBA van de, Capel PJA, Berden JHM (1986) Crossreactivity of human and murine anti-DNA antibodies with heparan sulphate: the major glycosaminoglycan in glomerular basement membrane. J Clin Invest 77:1824–1830

    Google Scholar 

  9. Brinkman K, Termaat RM, Jong J de, Brink HG van den, Berden JHM, Smeenk RJT (1989) Cross-reactive binding patterns of monoclonal antibodies to DNA are often caused by DNA/anti-DNA immune complexes. Res Immunol 140:595–612

    Google Scholar 

  10. Termaat RM, Brinkman K, Heuvel LPWJ van de, Smeenk RJT, Veerkamp JH, Berden JHM (1990) Crossreactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes. J Autoimmun 3:531–538

    Google Scholar 

  11. Brinkman K, Termaat RM, Berden JHM, Smeenk RJT (1990) Anti-DNA antibodies and lupus nephritis: the complexity of crossreactivity. Immunol Today 11:232–234

    Google Scholar 

  12. Feltkamp TEW (1975) The significance of the determination of anti-DNA and DNA/anti-DNA complexes. Scand J Rheumatol [Suppl] 11:5–67

    Google Scholar 

  13. Maini RN, Holborow EJ (1977) Detection and measurement of anti-DNA antibodies. Ann Rheum Dis 36[Suppl]

  14. Stollar BD (1975) The specifity and applications of antibodies to helical nucleic acids. CRC Crit Rev Biochem 3:45–69

    Google Scholar 

  15. Hasselbacher P, Leroy EC (1974) Serum DNA-binding activity in healthy subjects in rheumatic disease. Arthritis Rheum 17:63–71

    Google Scholar 

  16. Jain S, Markham R, Thomas HC, Sherlock S (1976) Doublestranded DNA-binding capacity of serum in acute and chronic liver disease. Clin Exp Immunol 26:35–41

    Google Scholar 

  17. Grennan DM, Sloan D, Behan A, Carson WD (1977) Clinical significance of antibodies to native DNA as measured by a DNA-binding technique. Ann Rheum Dis 36:30–33

    Google Scholar 

  18. Permin H, Halberg P, Christiansen P (1978) Antibodies against dsDNA in patients with connective tissue diseases. Acta Med Scand 203:61–65

    Google Scholar 

  19. Smeenk R (1986) A comparison of four different anti-DNA assays. In: Pal SB (ed) Immunoassay technology, vol 2. de Gruyter, Berlin New York, pp 145–166

    Google Scholar 

  20. Smeenk R, Brinkman K, Brink H van den, Swaak T (1990) A comparison of assays used for the detection of antibodies to DNA. Clin Rheumatol 9 [Suppl] 1:63–72

    Google Scholar 

  21. Wold RT, Young FE, Tan EM, Farr RS (1968) Deoxyribonucleic acid antibody: a method to detect its primary interaction with deoxyribonucleic acid. Science 161:806–807

    Google Scholar 

  22. Aarden LA, Lakmaker F, Feltkamp TEW (1976) Immunology of DNA. II. The effect of size and structure of the antigen on the Farr-assay. J Immunol Methods 10:39–48

    Google Scholar 

  23. Aarden LA, Smeenk R (1982) Immunochemical properties of antibodies to DNA and their influence on detection methods. In: Kalden JR, Feltkamp TEW (eds) Antibodies to nuclear antigens. Excerpta Medica, Amsterdam, pp 23–28

    Google Scholar 

  24. Smeenk R, Duin T, Aarden LA (1982) Influence of pH on the detection of low- and high-avidity anti-dsDNA. J Immunol Methods 55:361–373

    Google Scholar 

  25. Aarden LA, Smeenk R (1981) Measurements of antibodies specific for DNA. In: Lefkovits I, Pernis B (eds) Immunological methods, vol II. Academic Press, New York, pp 75–82

    Google Scholar 

  26. Feltkamp TEW, Kirkwood TBL, Maini RN, Aarden LA (1988) The first international standard for antibodies to dsDNA. Ann Rheum Dis 47:740–746

    Google Scholar 

  27. Riley RL, McGrath H Jr, Taylor RP (1979) Detection of low avidity anti-DNA antibodies in systemic lupus erythematosus. Arthritis Rheum 22:219–225

    Google Scholar 

  28. Smeenk R, Aarden LA (1980) The use of polyethylene glycol precipitation to detect low avidity anti-DNA antibodies in systemic lupus crythematosus. J Immunol Methods 39:165–180

    Google Scholar 

  29. Smeenk R, Lelij G van der, Aarden LA (1982) Avidity of antibodies to dsDNA. Comparison of IFT on Crithidia luciliae, Farr-assay and PEG-assay. J Immunol 128:73–78

    Google Scholar 

  30. Smeenk R, Lelij G van der, Aarden JA (1982) Measurements of low avidity anti-dsDNA by the Crithidia luciliae test and the PEG-assay. Clin Exp Immunol 50:603–610

    Google Scholar 

  31. Aarden LA, Groot ER de, Feltkamp TEW (1979) Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann NY Acad Sci USA 254:505–515

    Google Scholar 

  32. Smeenk R (1986) Detection of antibodies to DNA by enzymelinked immunosorbent assay (ELISA). In: Pal SB (ed) Immunoassay technology, vol 2. de Gruyter, Berlin New York, pp 121–144

    Google Scholar 

  33. Tan EM, Cohen AS, Fries JS, Masi AT, McShane DJ, Rothfield NF, Green Schaller J, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277

    Google Scholar 

  34. Smeenk RJT, brinkman K, Brink HG van den, Westgeest AAA (1988) Reaction patterns of monoclonal antibodies to DNA. J Immunol 140:3786–3792

    Google Scholar 

  35. Brinkman K, Termaat RM, Berden JHM, Smeenk RJT (1991) The specificity of the anti-DNA ELISA: a closer look. J Immunol Methods 139:91–100

    Google Scholar 

  36. Smeenk R, Brinkman K, Brink H van den, Termaat RM, Berden J, Nossent H, Swaak T (1990) Antibodies to DNA in patients with systemic lupus erythematosus. Their role in the diagnosis, the follow-up, and the pathogenesis of the disease. Clin Rheumatol 9 [Suppl] 1:100–110

    Google Scholar 

  37. Nossent JC, Huysen V, Smeenk RJT, Swaak AJG (1989) Low avidity antibodies to dsDNA as a diagnostic tool. Ann Rheum Dis 48:748–752

    Google Scholar 

  38. Swaak AJG, Smeenk R (1985) Clinical differences between SLE patients in relation to the avidity of their anti-dsDNA. In: Peeters H (ed) Protides of the biological fluids, 33rd edn. Pergamon, London, pp 317–320

    Google Scholar 

  39. Smeenk R, Rooyen A van, Swaak AJG (1988) Dissociation studies of DNA/anti-DNA complexes in relation to anti-DNA avidity. J Immunol Methods 109:27–35

    Google Scholar 

  40. Swaak AJG, Groenwold J, Aarden LA, Feltkamp TEW (1981) Detection of anti-dsDNA as a diagnostic tool. Ann Rheum Dis 40:45–49

    Google Scholar 

  41. Swaak AJG, Groenwold J, Bronsveld W (1986) Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. Ann Rheum Dis 45:359–366

    Google Scholar 

  42. McGrath H Jr, Biundo JJ Jr (1985) A longitudinal study of high and low avidity antibodies to double-stranded DNA in systemic lupus erythematosus. Arthritis Rheum 28:425–432

    Google Scholar 

  43. Nossent JC, Huysen V, Smeenk RJT, Swaak AJG (1989) Low avidity antibodies to dsDNA in SLE: a longitudinal study of their clinical significance. Ann Rheum Dis 48:677–682

    Google Scholar 

  44. Swaak AJG, Aarden LA, Statius van Eps LW, Feltkamp TEW (1979) Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum 22:226–235

    Google Scholar 

  45. Swaak AJG, Groenwold J, Aarden LA, Statius van Eps LW, Feltkamp TEW (1982) Prognostic value of anti-dsDNA in SLE. Ann Rheum Dis 41:388–395

    Google Scholar 

  46. Borg EJ ter, Horst G, Hummel EJ, Limburg PC, Kallenberg CGM (1990) Measurement of increases in anti-double stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term prospective study. 33:634–643

    Google Scholar 

  47. Swaak AJG, Smeenk R (1985) Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non systemic lupus erythematosus (SLE) patients with anti-dsDNA antibody (anti-dsDNA). Ann Rheum Dis 44:245–251

    Google Scholar 

  48. Izui S, Lambert PH, Miescher PA (1977) Failure to detect circulating DNA/anti-DNA complexes by four radioimmunochemical methods in patients with SLE. Clin Exp Immunol 30:384–392

    Google Scholar 

  49. Eilat D (1986) Cross-reactions of anti-DNA antibodies and the central dogma of lupus nephritis. Immunol Today 6:123–127

    Google Scholar 

  50. Ebling FM, Hahn BH (1980) Restricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus. Arthritis Rheum 23:392–402

    Google Scholar 

  51. Faaber P, Capel PJA, Rijke GPM, Vierwinden G, Putte LBA van de, Koene RAP (1984) Crossreactivity of anti-DNA antibodies with proteoglycans. Clin Exp Immunol 55:502–510

    Google Scholar 

  52. Faaber P, Rijke GPM, Smeenk RJT, Capel PJA, Putte LBA van de, Berden JHM (1985) Crossreactivity of anti-DNA antibodies: a new clue for the pathogenesis of SLE? In: Peeters H (ed) Protides of the biological fluids, 33rd edn. Pergamon, London, pp 405–408

    Google Scholar 

  53. Smeenk RJT, Lucassen WAM, Swaak AJG (1987) Is anticardiolipin activity a crossreaction of anti-DNA or a separate entity? Arthritis Rheum 30:607–617

    Google Scholar 

  54. Winfield JB, Faiferman I, Koffler D (1977) Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. J Clin Invest 59:90–96

    Google Scholar 

  55. Schmiedeke TMJ, Stöckl FW, Weber R Sugisaki Y, Batsford SR, Vogt A (1989) Histones have high affinity for the glomerular basement membrane. Relevance for immune complex formation in lupus nephritis. J Exp Med 169:1879–1894

    Google Scholar 

  56. Dighiero G, Lymberi P, Guilbert B, Ternynck T, Avrameas S (1986) natural autoantibodies constitute a substantial part of normal circulating immunoglobulins. Ann NY Acad Sci 475:135–145

    Google Scholar 

  57. Cairns E, Block J, Bell DA (1984) Anti-DNA autoantibody producing hybridomas of normal human lymphoid cell origin. J Clin Invest 74:880–889

    Google Scholar 

  58. Isenberg DA, Dudeney C, Williams W, Addison I, Charles S, Clarke J, Todd-Pokropek A (1987) Measurement of anti-DNA antibodies: a reappraisal using five different methods. Ann Rheum Dis 46:448–456

    Google Scholar 

  59. Tipping PG, Buchanan RRC, Riglar AG, Dimech WJ, Littlejohn GO, Holdworth SR (1988) Detection of anti-DNA antibodies: a comparison between two Farr assays, Crithidia luciliae and a human chromosomal substrate assay. Br J Rheumatol 27:206–210

    Google Scholar 

  60. Tzioufas AG, Terzoglou C, Stavropoulos ED, Athanasiadou S, Moutsopoulos HM (1990) Determination of anti-dsDNA antibodies by three different methods: comparison of sensitivity, specificity and correlation with lupus activity index (LAI). Clin Rheumatol 9:186–192

    Google Scholar 

  61. Termaat RM, Brinkman K, Nossent JC, Swaak AJG, Smeenk RJT, Berden JHM (1991) Anti-heparan sulfate reactivity in sera from SLE patients with renal or non-renal manifestations. Clin Exp Immunol 82:268–274

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smeenk, R.J.T., van den Brink, H.G., Brinkman, K. et al. Anti-dsDNA: choice of assay in relation to clinical value. Rheumatol Int 11, 101–107 (1991). https://doi.org/10.1007/BF00304496

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00304496

Key words

Navigation